Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies.

Lancet (London, England) ·Vol. 1 ·No. 7640 ·1970-01-31 ·Pages 230-3

Ridley M, Lynn R, Barrie D, Stead KC

Abstract

暂无摘要

MeSH Terms

Ampicillin/pharmacology Anti-Bacterial Agents/therapeutic use Bacteriophage Typing Chloramphenicol/pharmacology Cloxacillin/pharmacology Cross Infection/prevention & control Erythromycin/pharmacology Hospitals Humans Methicillin/pharmacology Microbial Sensitivity Tests Novobiocin/pharmacology Paratyphoid Fever/complications Penicillin G/pharmacology Penicillin Resistance Penicillins/pharmacology Sepsis/drug therapy Staphylococcal Infections/drug therapy,prevention & control Staphylococcus/drug effects,isolation & purification

Chemicals

Anti-Bacterial Agents Penicillins Novobiocin Erythromycin Chloramphenicol Ampicillin Cloxacillin Penicillin G Methicillin

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Ridley M

Lynn R

Barrie D

Stead K C

Article Info

Journal

Lancet (London, England)

Abbr.

Lancet

ISSN

0140-6736

DOI

10.1016/s0140-6736(70)90585-4

Published

1970-01-31

Pages

230-3

Language

English

Region

England

NLM ID

2985213R

Subset

External Links

PubMed source DOI: 10.1016/s0140-6736(70)90585-4 View journal details

Analysis Services

Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies.

Contact

WeChat Official Account